ArticleFrontiers in oncology2022

What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib.

Daniel P Petrylak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.